Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.75 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.75 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | STAT1 | P42224 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | TDO2 | P48775 | 1/20 | 0.46 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.45 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.45 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.45 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7871733 | 0.88 | CYP1A2 (0.75) | CYP1A2CYP2C9CYP2C19L3MBTL1SMN1; SMN2 | |
| SCHEMBL4440336 | 0.86 | CYP1A2 (1.00) | CYP1A2CYP2C9CYP2C19L3MBTL1SMN1; SMN2 | |
| SCHEMBL20646201 | 0.83 | CYP1A2 (0.77) | CYP1A2CYP2C9CYP2C19GRM4L3MBTL1 | |
| SCHEMBL15680117 | 0.83 | CYP2C9 (0.67) | CYP1A2CYP2C9CYP2C19L3MBTL1SMN1; SMN2 | |
| SCHEMBL19411114 | 0.82 | CYP1A2 (0.75) | CYP1A2CYP2C9CYP2C19L3MBTL1SMN1; SMN2 | |
| SCHEMBL8112973 | 0.81 | CYP1A2 (0.64) | CYP1A2CYP2C9CYP2C19L3MBTL1SMN1; SMN2 | |
| SCHEMBL15972268 | 0.81 | GRM4 (0.59) | CYP1A2CYP2C9CYP2C19GRM4L3MBTL1 | |
| SCHEMBL879728 | 0.81 | GRM4 (0.59) | GRM4STAT1SMN1; SMN2MAPTLMNA | |
| SCHEMBL30159535 | 0.81 | GRM4 (0.59) | GRM4STAT1SMN1; SMN2MAPTLMNA | |
| SCHEMBL21167297 | 0.81 | CYP1A2 (0.73) | CYP1A2CYP2C9CYP2C19L3MBTL1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9944657-B2 | Luminescent lanthanide chelates having three chromophores an their use | RADIOMETER TURKU OY (FI) | 2018-04-17 | — | — | US | disclosed |
| CN-103890137-B | There are three chromophoric luminescent lanthanide chelates and application thereof | DHR芬兰公司 | 2016-08-24 | — | — | CN | disclosed |
| EP-2753674-B1 | LUMINESCENT LANTHANIDE CHELATES HAVING THREE CHROMOPHORES AND THEIR USE | DHR FINLAND OY (FI) | 2016-02-10 | — | — | EP | disclosed |
| EP-2753674-B1 | LUMINESCENT LANTHANIDE CHELATES HAVING THREE CHROMOPHORES AND THEIR USE | DHR FINLAND OY (FI) | 2016-02-10 | — | — | EP | disclosed |
| US-20130210165-A1 | Luminescent Lanthanide Chelates Having Three Chromophores and Their Use | DHR FINLAND OY (FI) | 2013-08-15 | — | — | US | disclosed |
| US-20130210165-A1 | Luminescent Lanthanide Chelates Having Three Chromophores and Their Use | DHR FINLAND OY (FI) | 2013-08-15 | — | — | US | disclosed |
| WO-2013026790-A9 | LUMINESCENT LANTHANIDE CHELATES HAVING THREE CHROMOPHORES AND THEIR USE | DHR FINLAND OY (FI) | 2013-05-23 | — | — | WO | disclosed |
| WO-2013026790-A1 | LUMINESCENT LANTHANIDE CHELATES HAVING THREE CHROMOPHORES AND THEIR USE | DHR FINLAND OY (FI) | 2013-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210165-A1 | Luminescent Lanthanide Chelates Having Three Chromophores and Their Use | GLB1, SSB, LGALS3BP | CYP1A2 3913/4885CYP2C9 3265/4885CYP2C19 3971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.